ORIGINAL PAPER
Role of epicardial fat thickness and irisin levels in early prediction of cardiac dysfunction in children
and adolescents with type 1 diabetes mellitus
1
Department of Paediatrics, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt
2
Department of Clinical and Chemical Pathology, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt
Submission date: 2023-05-29
Final revision date: 2023-07-09
Acceptance date: 2023-07-09
Publication date: 2023-12-15
Corresponding author
Abeer M. Nour ElDin Abd ElBaky
Prof. Abeer Mohamed Nour ElDin Abd ElBaky, Department of Paediatrics, Medical Research and Clinical Studies Institute (MRCSI), National Research Centre, Cairo, Egypt
Prof. Abeer Mohamed Nour ElDin Abd ElBaky, Department of Paediatrics, Medical Research and Clinical Studies Institute (MRCSI), National Research Centre, Cairo, Egypt
Pediatr Pol 2023;98(4):278-284
KEYWORDS
TOPICS
ABSTRACT
Introduction:
to assess the role of epicardial fat thickness and irisin in early prediction of cardiac dysfunction in children and adolescents with type 1 diabetes mellitus and correlate them with echocardiographic parameters and lipid profile.
Material and methods:
Sixty-three type 1 diabetic children and adolescents were recruited from the Pediatric Diabetic Clinic, National Research Centre. Thirty-four healthy children, matched for age and sex, served as controls. All patients were insulin dependent with at least 3-year duration of the disease since diagnosis. Venous blood was withdrawn under complete aseptic precautions from fasting subjects; sera were collected for evaluation of glycated haemoglobin (HbA1C), lipid profile and irisin levels. Two-dimensional echocardiography was performed for measurement of interventricular septal thickness in diastole, left atrial diameter (LAD), aortic root diameter, mitral E and A wave, left ventricular internal dimension in diastole, percent fractional shortening (FS%), percent ejection fraction, left ventricular mass, and epicardial fat thickness. Patients were further divided into two groups according to their glycaemic control (< 7.00, ≥ 7.0) for comparison of echocardiographic parameters and irisin.
Results:
Echocardiographic study revealed a statistically significant increase in LAD, FS%, and epicardial fat thickness in patients compared to controls (p = 0.000, 0.014, and 0.000 respectively). Triglyceride and irisin levels were significantly increased in patients compared to controls (p = 0.012, 0.015 respectively). Epicardial fat thickness positively correlated with left atrial diameter (p = 0.009) and left ventricular mass (p = 0.000). Irisin was positively correlated with E/A ratio (p = 0.05).
Conclusions:
The findings of the present study probably indicate the beginning of a state of metabolically induced diastolic dysfunction. Echocardiography should be performed in type 1 diabetic patients on a regular basis for early detection of subclinical cardiac dysfunction.
to assess the role of epicardial fat thickness and irisin in early prediction of cardiac dysfunction in children and adolescents with type 1 diabetes mellitus and correlate them with echocardiographic parameters and lipid profile.
Material and methods:
Sixty-three type 1 diabetic children and adolescents were recruited from the Pediatric Diabetic Clinic, National Research Centre. Thirty-four healthy children, matched for age and sex, served as controls. All patients were insulin dependent with at least 3-year duration of the disease since diagnosis. Venous blood was withdrawn under complete aseptic precautions from fasting subjects; sera were collected for evaluation of glycated haemoglobin (HbA1C), lipid profile and irisin levels. Two-dimensional echocardiography was performed for measurement of interventricular septal thickness in diastole, left atrial diameter (LAD), aortic root diameter, mitral E and A wave, left ventricular internal dimension in diastole, percent fractional shortening (FS%), percent ejection fraction, left ventricular mass, and epicardial fat thickness. Patients were further divided into two groups according to their glycaemic control (< 7.00, ≥ 7.0) for comparison of echocardiographic parameters and irisin.
Results:
Echocardiographic study revealed a statistically significant increase in LAD, FS%, and epicardial fat thickness in patients compared to controls (p = 0.000, 0.014, and 0.000 respectively). Triglyceride and irisin levels were significantly increased in patients compared to controls (p = 0.012, 0.015 respectively). Epicardial fat thickness positively correlated with left atrial diameter (p = 0.009) and left ventricular mass (p = 0.000). Irisin was positively correlated with E/A ratio (p = 0.05).
Conclusions:
The findings of the present study probably indicate the beginning of a state of metabolically induced diastolic dysfunction. Echocardiography should be performed in type 1 diabetic patients on a regular basis for early detection of subclinical cardiac dysfunction.
REFERENCES (33)
1.
Da Rocha Fernandes J, Ogurtsova K, Linnenkamp U, et al. IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract 2016; 117: 48-54.
2.
Schäfer M, Nadeau KJ, Reusch JEB. Cardiovascular disease in young People with type 1 diabetes: search for cardiovascular biomarkers. J Diabetes Complications 2020; 34: 107651.
3.
Mahabadi Amir A, Massaro Joseph M, Rosito Guido A, et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 2009; 30: 850-856.
4.
Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005; 2: 536-543.
5.
Xin C, Liu J, Zhang J, et al. Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway. Int J Obes (Lond) 2016; 40: 443-451.
6.
Xie C, Zhang Y, Tran TD, et al. Irisin controls growth, intracellular Ca2+ signals, and mitochondrial thermogenesis in cardiomyoblasts. PLoS One 2015; 10: e0136816.
7.
Zhang W, Chang L, Zhang C, et al. Central and peripheral irisin differentially regulate blood pressure. Cardiovasc Drugs Ther 2015; 29: 121-127.
8.
Binay Ç, Paketçi C, Guzel S, et al. Serum irisin and oxytocin levels as predictors of metabolic parameters in obese children. J Clin Res Pediatr Endocrinol 2017; 9: 124-131.
9.
Cho DH, Joo HJ, Kim MN, et al. Association between epicardial adipose tissue, high-sensitivity C-reactive protein and myocardial dysfunction in middle-aged men with suspected metabolic syndrome. Cardiovasc Diabetol 2018; 17: 95.
10.
Khaing NEE, Shyong TE, Lee J, et al. Epicardial and visceral adipose tissue in relation to subclinical atherosclerosis in a Chinese population. PLoS One 2018; 13: e0196328.
11.
Brown A, Reynolds LR, Bruemmer D. Intensive glycemic control and cardiovascular disease: an update. Nat Rev Cardiol 2010; 7: 369-375.
12.
Egyptian growth curves. Diabetes Endocrine Metabolism Pediatric Unit Cairo University Childern’s Hospital 2009. Available at: http://dempuegypt.blogspot.com (access: 10 October 2019).
13.
Devereux RB, Aonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
14.
Yazici D, Ozben B, Yavuz D, et al. Epicardial adipose tissue thickness in type 1 diabetic patients. Endocrine 2011; 40: 250-255.
15.
Ahmad FA, Metwalley KA, Mohamed IL. Association of epicardial fat with diastolic and vascular functions in children with type 1 diabetes. Pediatr Cardiol 2022; 43: 999-1010.
16.
Abd-El Aziz FM, Abdelghaffar S, Hussien EM, et al. Evaluation of cardiac functions in children and adolescents with type 1 diabetes. J Cardiovasc Ultrasound 2017; 25: 12-19.
17.
Flachskampf FA, Biering-Sorensen T, Solomon SD, et al. Cardiac imaging to evaluate left ventricular diastolic function. JACC Cardiovasc Imaging 2015; 8: 1071-1793.
18.
Labombarda F, Leport M, Morello R, et al. Longitudinal left ventricular strain impairment in type 1 diabetes children and adolescents: a 2D speckle strain imaging study. Diabetes Metab 2014; 40: 292-298.
19.
Bradley TJ, Slorach C, Mahmud FH, et al. Early changes in cardiovascular structure and function in adolescents with type 1 diabetes. Cardiovasc Diabetol 2016; 15: 31.
20.
Bjornstad P, Truong U, Pyle L, et al. Youth with type 1 diabetes have worse strain and less pronounced sex differences in early echocardiographic markers of diabetic cardiomyopathy compared to their normoglycemic peers: aRESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) Study. J Diabetes Complications 2016; 30: 1103-1110.
21.
Yoldaş T, Örün UA, Sagsak E, et al. Subclinical left ventricular systolic and diastolic dysfunction in type 1 diabetic children and adolescents with good metabolic control. Echocardiography 2018; 35: 227-233.
22.
Altun G, Babaoglu K, Binnetoglu K, et al. Subclinical left ventricular longitudinal and radial systolic dysfunction in children and adolescents with type 1 diabetes mellitus. Echocardiography 2016; 33: 1032-1039.
23.
Ramadan MA, Elghandour MA, Adel HM, et al. Evaluation of left ventricular diastolic and systolic function in children with type 1 diabetes mellitus using echocardiography and tissue Doppler imaging. Alexandria J Pediatr 2020; 32: 86-92.
24.
Gotzsche O, Darwish A, Gotzsche L, et al. Incipient cardiomyopathy in young insulin-dependent diabetic patients: a seven-year prospective Doppler echocardiographic study. Diabet Med 1996; 13: 834-840.
25.
Packer M. Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. J Am Coll Cardiol 2018; 71: 2360-2372.
26.
Abd El Dayem SM, Battah, AA, El Bohy A, et al. Irisin in adolescent type 1 diabetic patients and its relation to diabetes control and atherosclerosis. Open Access Maced J Med Sci 2020; 8: 1262-1265.
27.
Aydin S, Kuloglu T, Aydin S, et al. A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues. Peptides 2014; 61:130-136.
28.
Akyuz A, Mert B, Gur DO, et al. Association of lower irisin levels with diabetes mellitus: Irrespective of coronary collateral circulation, and syntax score. North Clin Istanb 2021; 8: 607-614.
29.
Noorani M, Ramaiya K, Manji K. Glycemic control in type 1 diabetes mellitus among children and adolescents in a resource limited setting in Dar es Salaam – Tanzania. BMC Endocr Disord 2016; 16: 29.
30.
Çetin M, Kocaman SA, Durakoğlugil ME, et al. Effect of epicardial adipose tissue on diastolic functions and left atrial dimension in untreated hypertensive patients with normal systolic function. J Cardiol 2013; 61: 359-364.
31.
Iacobellis G, Ribaudo MC, Zappaterreno A, et al. Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiol 2004; 94: 1084-1087.
32.
Tang L, Tong Y, Zhang F, et al. The association of circulating irisin with metabolic risk factors in Chinese adults: A cross-sectional community-based study. BMC Endocr Disord 2019; 19: 147.
33.
Faienza MF, Brunetti G, Sanesi L, et al. High irisin levels are associated with better glycemic control and bone health in children with type 1 diabetes. Diabetes Res Clin Prac 2018; 141: 10-17.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
